Morgan Stanley Hexo Corp. Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.17 - $0.26 $12,091 - $18,492	-71,126 Reduced 16.68%	355,387 $62,000
Q2 2022 Oct 27, 2022	SELL	$0.2 - $0.61 $15,615 - $47,626	-78,077 Reduced 15.47%	426,513 $90,000
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.61 $15,615 - $47,626	-78,077 Reduced 15.47%	426,513 $90,000
Q1 2022 Oct 27, 2022	BUY	$0.48 - $0.74 $37,476 - $57,776	78,077 Added 18.31%	504,590 $313,000
Q1 2022 May 13, 2022	SELL	$0.48 - $0.74 $4.76 Million - $7.34 Million	-9,920,019 Reduced 95.16%	504,590 $313,000
Q4 2021 Feb 14, 2022	BUY	$0.7 - $1.94 $3.55 Million - $9.84 Million	5,071,430 Added 94.74%	10,424,609 $7.28 Million
Q3 2021 Nov 15, 2021	BUY	$1.82 - $5.71 $9.74 Million - $30.6 Million	5,353,179 New	5,353,179 $9.85 Million

23.7K

Ticker HEXO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 601,395,008
Description
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.